GTHX
G1 Therapeutics Inc

4,465
Loading...
Loading...
News
all
press releases
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies Global Cancer Rates Surge as Biotech Innovators Work on New Therapies PR Newswire VANCOUVER, BC, Sept. 20, 2024 Issued on behalf...
PR Newswire·1y ago
News Placeholder
More News
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, OBDC, PETQ on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, OBDC, PETQ on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, OBDC, PETQ on Behalf of Shareholders...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BAYA, RCFA, OBDC, GTHX on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BAYA, RCFA, OBDC, GTHX on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BAYA, RCFA, OBDC, GTHX on Behalf of...
PR Newswire·1y ago
News Placeholder
G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of G1 Therapeutics, Inc. (NasdaqGS: GTHX) to...
Business Wire·1y ago
News Placeholder
Kuehn Law Encourages BAYA, RCFA, OBDC, and GTHX Investors to Contact Law Firm
Kuehn Law Encourages BAYA, RCFA, OBDC, and GTHX Investors to Contact Law Firm Kuehn Law Encourages BAYA, RCFA, OBDC, and GTHX Investors to Contact Law Firm PR Newswire NEW YORK, Aug. 9, 2024 NEW...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, GTHX, RNST on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, GTHX, RNST on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCM, GTHX, RNST on Behalf of Shareholders...
PR Newswire·1y ago
News Placeholder
Analyst Ratings For G1 Therapeutics
Latest Ratings for GTHX DateFirmActionFromTo Nov 2021JP MorganDowngradesNeutralUnderweight Nov 2021HC Wainwright & Co.MaintainsBuy Nov 2021Raymond JamesMaintainsOutperform View More Analyst...
Benzinga·1y ago
News Placeholder
What's Going On With G1 Therapeutics Stock?
According to a report, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics. According to the report, one offer from TerSera is rumored to have a contingent value...
Benzinga·1y ago
News Placeholder
Evaluating G1 Therapeutics: Insights From 5 Financial Analysts
Latest Ratings for GTHX DateFirmActionFromTo Nov 2021JP MorganDowngradesNeutralUnderweight Nov 2021HC Wainwright & Co.MaintainsBuy Nov 2021Raymond JamesMaintainsOutperform View More Analyst...
Benzinga·1y ago
News Placeholder
Biotech Innovations Paving the Way in Breast Cancer Fight
Biotech Innovations Paving the Way in Breast Cancer Fight Biotech Innovations Paving the Way in Breast Cancer Fight PR Newswire VANCOUVER, BC, April 11, 2024 FN Media Group Presents USA News Group...
PR Newswire·1y ago

Latest GTHX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.